Sonis ST - Search Results

1

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Al-Dasooqi N, et al. Among authors: sonis st. Support Care Cancer. 2013 Nov;21(11):3233-41. doi: 10.1007/s00520-013-1900-x. Epub 2013 Jul 11. Support Care Cancer. 2013. PMID: 23842598 Review.

2

Oral mucositis in cancer therapy.

Sonis ST. Sonis ST. J Support Oncol. 2004 Nov-Dec;2(6 Suppl 3):3-8. J Support Oncol. 2004. PMID: 15605918 Review.

3

New thoughts on the pathobiology of regimen-related mucosal injury.

Anthony L, Bowen J, Garden A, Hewson I, Sonis S. Anthony L, et al. Support Care Cancer. 2006 Jun;14(6):516-8. doi: 10.1007/s00520-006-0058-1. Epub 2006 Apr 1. Support Care Cancer. 2006. PMID: 16583189 Review.

4

Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy.

Logan RM, Gibson RJ, Sonis ST, Keefe DM. Logan RM, et al. Among authors: sonis st. Oral Oncol. 2007 Apr;43(4):395-401. doi: 10.1016/j.oraloncology.2006.04.011. Epub 2006 Sep 18. Oral Oncol. 2007. PMID: 16979925

5

Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.

Blijlevens N, Sonis S. Blijlevens N, et al. Ann Oncol. 2007 May;18(5):817-26. doi: 10.1093/annonc/mdl332. Epub 2006 Oct 9. Ann Oncol. 2007. PMID: 17030544 Free article. Review.

6

Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies.

Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Vera-Llonch M, et al. Support Care Cancer. 2007 May;15(5):491-6. doi: 10.1007/s00520-006-0176-9. Epub 2006 Dec 1. Support Care Cancer. 2007. PMID: 17139495

7

Updated clinical practice guidelines for the prevention and treatment of mucositis.

Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Keefe DM, et al. Among authors: sonis st. Cancer. 2007 Mar 1;109(5):820-31. doi: 10.1002/cncr.22484. Cancer. 2007. PMID: 17236223 Free article.

8

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.

Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. Logan RM, et al. Among authors: sonis st. Cancer Treat Rev. 2007 Aug;33(5):448-60. doi: 10.1016/j.ctrv.2007.03.001. Epub 2007 May 15. Cancer Treat Rev. 2007. PMID: 17507164 Review.

9

Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.

Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Logan RM, et al. Among authors: sonis st. Cancer Chemother Pharmacol. 2008 Jun;62(1):33-41. doi: 10.1007/s00280-007-0570-0. Epub 2007 Aug 17. Cancer Chemother Pharmacol. 2008. PMID: 17703303

10

Pathobiology of oral mucositis: novel insights and opportunities.

Sonis ST. Sonis ST. J Support Oncol. 2007 Oct;5(9 Suppl 4):3-11. J Support Oncol. 2007. PMID: 18046993 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page